bmi for tirzepatide reduces HbA1c, children and adolescents with type 2 diabetes What is the indication for
Description
Additional studies are underway to see if any unique changes in immunological or inflammatory pathways occur with this medication
The safety profile in pediatric patients through Week 16 was similar to that of adults with AD
Results may vary and are not guaranteed by Nurx
Purity, identity, material content, sterility and clinical suitability are separate questions
The FDA approved semaglutide for chronic weight management in 2021 under the brand name Wegovy, making it the first GLP-1 approved specifically for weight loss in adults with obesity or overweight with weight-related conditions
